TXG
HOLD / NEUTRALNeutralComposite
58.70
Technical
97.80
Fundamental
32.70
Rank
—
Price
74.39
Hurst
0.59
As of
Sep 16, 2026
Daily
10x Genomics, Inc.
HealthcareMedical Devices10x Genomics develops and markets hardware, reagents, and analytical software for studying biological samples across academic, government, and pharmaceutical sectors worldwide. Its product portfolio includes the Chromium platform for single-cell analysis using microfluidic technology, the Visium platform for spatial transcriptomics using DNA arrays, and the Xenium Analyzer for detecting RNA targets within tissue sections. The company also offers complementary software tools for processing and visualizing genomic and spatial data from these instruments.
Market cap
$10.0B
P/E (trailing)
—
P/E (forward)
378.55
PEG ratio
—
Dividend yield
—
Beta
2.08
52w range
11.16 – 79.94
Return on equity
-9.40%
Profit margin
-12.18%
Revenue growth
-12.70%
Earnings growth
—
Price history
1Y: 72.68 (+447.7%) · range 11.34–74.39
Cycle position
88/ 100 cycle scoreEXIT ZONE
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 0 · NOT READY · exit proximity 58
Conviction
29/ 100 · maturity 100%
VScore.4024
Buildup.2071
EMA entry setup.250
Fundamentals.1533
Volume profile
POC
22.09
Price vs POC
+229.1%
Overhead supply
1%
Runway
open sky
Value area 19.15–47.34 · 1% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| trend-signal | 1.000 | Sep 16, 2026 |
| earnings-surprise | 0.033 | Sep 4, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +11.46% | +11.46% | 9/20d |
| 40d | +11.46% | +11.46% | 9/40d |